Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2023-06-29 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window for insiders due to upcoming financial results for the quarter ended June 30, 2023. It references the SEBI regulations on insider trading and mentions that the unaudited standalone and consolidated financial results will be declared soon, but does not contain any financial data or the results themselves. The document is short (1662 characters) and serves as an announcement related to compliance and trading restrictions ahead of a financial report. It does not contain the financial report or detailed financial information. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-06-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call discussing the Q4 FY23 and full year FY23 performance and business update of Mankind Pharma Limited. It includes detailed management commentary on financial results, business strategy, and market performance. The presence of a moderator, management speakers, and Q&A format confirms it is a call transcript. The document references the earnings call held on May 31, 2023, and includes detailed financial and operational discussion typical of earnings calls. Therefore, the document fits the category of a Call Transcript (CT).
2023-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (1296 characters) informing about the availability of an audio recording of a Performance and Business Update Call for Q4FY23 & FY23. It references a call with senior management and provides a link to the audio recording. There are no financial statements or detailed financial data included. The document is an announcement of the call recording, not the transcript or the report itself. According to the definitions, a full transcript of a call would be classified as Call Transcript (CT), but this is only an announcement of the recording availability. Given the short length and nature of the document, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification of the call recording availability, not the call transcript itself.
2023-05-31 English
Financial Result Updates
Regulatory Filings
2023-05-31 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is dated 31st May 2023 and is addressed to stock exchanges in India, referencing the publication of consolidated audited financial results for the quarter and financial year ended 31st March 2023. It mentions Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The text includes extracts of consolidated audited financial results and is a formal communication to stock exchanges about the newspaper publication of these results. The document is about announcing the publication of the audited financial results rather than containing the full detailed financial report itself. Therefore, it fits the category of a Report Publication Announcement (RPA) rather than the full Annual Report or Earnings Release. The length (15,000 characters) is substantial but the content is primarily an announcement of the publication of the financial results in newspapers, not the full report itself.
2023-05-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, containing the 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' (UPSI). It is a compliance document related to insider trading regulations and fair disclosure policies. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of voting results, nor a report of share transactions or capital changes. It is a regulatory compliance filing related to governance and disclosure practices but does not fit into governance information (CGR) as it is specifically about insider trading regulation compliance. Given the nature and regulatory context, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other categories.
2023-05-31 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.